Products

Personalised treatment plans with customisable options that best fit patients' specific needs.
Background Image
tabs dropdown arrow

Innovation is at our core

Nearly 100 years ago, we delivered an innovation that moved the management and treatment of diabetes forward. That journey toward better solutions to control and to simplify everyday realities continues. Over 30 million people trust our products for their insulin injections every day. At embecta, we are solely focused on continuing to provide the highest quality solutions and advancing a new generation of life-changing innovation:

 

  • Shorter needles for easier and more comfortable injections from start to finish1
  • Insulin syringe available in multiple barrel capacities and scale combinations to customise dosing2
  • Patient-facing tools and resources to help as a resource to help your patients with their day-to-day management of diabetes

  • Pen Needles 

    Our products are diligently designed to enable people who are living with diabetes to benefit from comfortable, effective diabetes care

    Learn More

    forward-arrow

  • Insulin Syringes

    Portfolio of needle lengths and barrel sizes designed to help to meet the needs of people with diabetes

    Learn More

    forward-arrow

Make every day an opportunity

Advancing diabetes care will take the best efforts of the diabetes community. Working together with healthcare providers, advocacy groups and people living with diabetes around the world informs our mission to provide innovative technology and comprehensive care resources to help to elevate the global standard of diabetes care.

References

  1. Whooley S, Briskin T, Gibney MA, Blank LR, Berube J, Pflug BK. Evaluating the user performance and experience with a re-engineered 4mm × 32G pen needle: a randomised trial with similar length/gauge needles. Diabetes Ther. 2019;10(2):697-712.

  2. BD Insulin Syringe 510(k) Summary K190054. 510(k) Premarket Notification Database. https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190054.pdf. Published on 21 October 2019. Updated on 5 April 2021. Accessed on 6 April 2021.